Table 1.
Clinical information description of hepatocellular carcinoma patients in The Cancer Genome Atlas
|
Description
|
Samples, n = 371
|
Percentage
|
| Sex | ||
| Male | 249 | 67.11 |
| Female | 121 | 32.61 |
| Others | 1 | 0.27 |
| Race | ||
| White | 184 | 49.60 |
| Asian | 158 | 42.59 |
| Black or African American | 16 | 4.31 |
| Others | 13 | 3.50 |
| Vital status | ||
| Alive | 240 | 64.69 |
| Dead | 130 | 35.14 |
| Others | 1 | 0.27 |
| Age at diagnosis | ||
| ≥ 60-years-old | 197 | 53.10 |
| < 60-years-old | 169 | 45.55 |
| Others | 5 | 1.35 |
| AJCC pathologic T | ||
| T1 | 180 | 48.52 |
| T2 | 92 | 24.80 |
| T2a | 1 | 0.27 |
| T2b | 1 | 0.27 |
| T3 | 45 | 12.13 |
| T3a | 29 | 7.82 |
| T3b | 6 | 1.62 |
| T4 | 13 | 3.50 |
| TX | 1 | 0.27 |
| Others | 1 | 0.27 |
| AJCC system for tumor staging | ||
| N0 | 239 | 64.42 |
| N1 | 4 | 1.08 |
| Nx | 91 | 24.53 |
| Others | 2 | 0.54 |
| AJCC system for metastasis staging | ||
| M0 | 265 | 71.43 |
| M1 | 4 | 1.08 |
| Mx | 101 | 27.22 |
| Others | 1 | 0.27 |
| AJCC system for stage | ||
| Stage I | 170 | 45.82 |
| Stage II | 86 | 23.18 |
| Stage III | 3 | 0.81 |
| Stage IIIA | 65 | 17.52 |
| Stage IIIB | 8 | 2.16 |
| Stage IIIC | 9 | 2.43 |
| Stage IV | 2 | 0.54 |
| Stage IVA | 1 | 0.27 |
| Stage IVB | 2 | 0.54 |
| Others | 25 | 6.74 |
| Prior malignancy | ||
| Yes | 35 | 9.43 |
| No | 335 | 90.30 |
| Others | 1 | 0.27 |
| Treatment or therapy | ||
| Yes | 38 | 10.24 |
| No | 309 | 83.28 |
| Others | 24 | 6.47 |
AJCC: American Joint Committee on Cancer.